Immutep welcomes constructive feedback from German regulator for phase III lung cancer trial
Immutep (ASX:IMM) has welcomed constructive feedback from German regulatory authority, Paul-Ehrlichlnstitut (PEI)…
Fri, 26 Apr | Last | Change |
3:27pm | 7,574.8 | 108 |
Currently Trading at Fri, 26 Apr 3:29pm |
S&P/ASX Sm. Ords. | 2,965.0 | 36.7 | 1.22% |
All Ordinaries | 7,835.6 | 102 | 1.28% |
S&P/ASX 100 | 6,358.7 | 91.0 | 1.41% |
RCR | RINCON RESOURCES LIMITED | 6.5¢ | 58.5% |
ASE | ASTUTE METALS NL | 6.0¢ | 46.3% |
VNL | VINYL GROUP LTD | 12.5¢ | 30.2% |
ADR | ADHERIUM LIMITED | 2.2¢ | 24.1% |
FNR | FAR NORTHERN RESOURCES LIMITED | 15.0¢ | 21.1% |
AJX | ALEXIUM INTERNATIONAL GROUP LIMITED | 1.2¢ | 20.0% |